<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1414" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1414/" /><meta name="ncbi_pagename" content="SGCE Myoclonus-Dystonia - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>SGCE Myoclonus-Dystonia - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="SGCE Myoclonus-Dystonia" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/08/08" /><meta name="citation_author" content="Deborah Raymond" /><meta name="citation_author" content="Rachel Saunders-Pullman" /><meta name="citation_author" content="Laurie Ozelius" /><meta name="citation_pmid" content="20301587" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1414/" /><meta name="citation_keywords" content="Dystonia 11 (DYT11)" /><meta name="citation_keywords" content="DYT-SGCE" /><meta name="citation_keywords" content="Dystonia 11 (DYT11)" /><meta name="citation_keywords" content="DYT-SGCE" /><meta name="citation_keywords" content="Epsilon-sarcoglycan" /><meta name="citation_keywords" content="SGCE" /><meta name="citation_keywords" content="SGCE Myoclonus-Dystonia" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="SGCE Myoclonus-Dystonia" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Deborah Raymond" /><meta name="DC.Contributor" content="Rachel Saunders-Pullman" /><meta name="DC.Contributor" content="Laurie Ozelius" /><meta name="DC.Date" content="2019/08/08" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1414/" /><meta name="description" content="SGCE myoclonus-dystonia (SGCE-M-D) is a movement disorder characterized by a combination of rapid, brief muscle contractions (myoclonus) and/or sustained twisting and repetitive movements that result in abnormal postures (dystonia). The myoclonic jerks typical of SGCE-M-D most often affect the neck, trunk, and upper limbs with less common involvement of the legs. Approximately 50% of affected individuals have additional focal or segmental dystonia, presenting as cervical dystonia and/or writer's cramp. Non-motor features may include alcohol abuse, obsessive-compulsive disorder (OCD), and anxiety disorders. Symptom onset is usually in the first decade of life and almost always by age 20, but ranges from age six months to 80 years. Most affected adults report a dramatic reduction in myoclonus in response to alcohol ingestion. SGCE-M-D is compatible with an active life of normal span." /><meta name="og:title" content="SGCE Myoclonus-Dystonia" /><meta name="og:type" content="book" /><meta name="og:description" content="SGCE myoclonus-dystonia (SGCE-M-D) is a movement disorder characterized by a combination of rapid, brief muscle contractions (myoclonus) and/or sustained twisting and repetitive movements that result in abnormal postures (dystonia). The myoclonic jerks typical of SGCE-M-D most often affect the neck, trunk, and upper limbs with less common involvement of the legs. Approximately 50% of affected individuals have additional focal or segmental dystonia, presenting as cervical dystonia and/or writer's cramp. Non-motor features may include alcohol abuse, obsessive-compulsive disorder (OCD), and anxiety disorders. Symptom onset is usually in the first decade of life and almost always by age 20, but ranges from age six months to 80 years. Most affected adults report a dramatic reduction in myoclonus in response to alcohol ingestion. SGCE-M-D is compatible with an active life of normal span." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1414/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/myo-dystonia/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1414/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D0A34E040AF810000000000E80058.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1414_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1414_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/etha/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/short/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1414_"><span class="title" itemprop="name"><i>SGCE</i> Myoclonus-Dystonia</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Dystonia 11 (DYT11), DYT-SGCE</div><p class="contrib-group"><span itemprop="author">Deborah Raymond</span>, MS, <span itemprop="author">Rachel Saunders-Pullman</span>, MD, MPH, and <span itemprop="author">Laurie Ozelius</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1414_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1414_ai__"><div class="contrib half_rhythm"><span itemprop="author">Deborah Raymond</span>, MS<div class="affiliation small">Department of Neurology<br />Mount Sinai Beth Israel<br />New York, New York<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.ianistnuom@dnomyard" class="oemail">gro.ianistnuom@dnomyard</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Rachel Saunders-Pullman</span>, MD, MPH<div class="affiliation small">Department of Neurology<br />Mount Sinai Beth Israel<br />New York, New York<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.ianistnuom@namllup-srednuas.lehcar" class="oemail">gro.ianistnuom@namllup-srednuas.lehcar</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Laurie Ozelius</span>, PhD<div class="affiliation small">Department of Neurology<br />Massachusetts General Hospital<br />Charlestown, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.srentrap@suilezol" class="oemail">gro.srentrap@suilezol</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 21, 2003</span>; Last Update: <span itemprop="dateModified">August 8, 2019</span>.</p><p><em>Estimated reading time: 22 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="myo-dystonia.Summary" itemprop="description"><h2 id="_myo-dystonia_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>SGCE</i> myoclonus-dystonia (<i>SGCE</i>-M-D) is a movement disorder characterized by a combination of rapid, brief muscle contractions (myoclonus) and/or sustained twisting and repetitive movements that result in abnormal postures (dystonia). The myoclonic jerks typical of <i>SGCE</i>-M-D most often affect the neck, trunk, and upper limbs with less common involvement of the legs. Approximately 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have additional focal or segmental dystonia, presenting as cervical dystonia and/or writer's cramp. Non-motor features may include alcohol abuse, obsessive-compulsive disorder (OCD), and anxiety disorders. Symptom onset is usually in the first decade of life and almost always by age 20, but ranges from age six months to 80 years. Most affected adults report a dramatic reduction in myoclonus in response to alcohol ingestion. <i>SGCE</i>-M-D is compatible with an active life of normal span.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>SGCE</i>-M-D is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with characteristic clinical features by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SGCE</i>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Class 1 evidence supports the improvement of myoclonus and dystonia with zonisamide. Benzodiazepines (particularly clonazepam) and antiepileptics used to treat myoclonus (especially valproate and levitiracetam) also improve myoclonus in individuals with myoclonus-dystonia. The response to other antiepileptics (e.g., topiramate) is more variable. Anticholinergic medication may improve dystonia. Botulinum toxin injection may be especially helpful for cervical dystonia. Improvement with L-5-hydroxytryptophan, L-dopa, and the salt of sodium oxybate has been reported. Deep brain stimulation has improved both myoclonus and dystonia, with most targeting the globus pallidus interna (GPi); however, success with ventral intermediate nucleus of the thalamus (VIM) target has also been reported.</p><p><i>Other</i>: Symptoms of <i>SGCE</i>-M-D often improve short term with ingestion of alcohol, but the risk of addiction recommends against its long-term use.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>SGCE</i>-M-D is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner with <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> determined by the parental origin of the altered <i>SGCE</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>: an <i>SGCE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on the paternally derived (expressed) <i>SGCE</i> allele generally results in disease; a pathogenic variant on the maternally derived (silenced) <i>SGCE</i> allele typically does not result in disease. Most individuals with <i>SGCE</i>-M-D inherited the disorder from a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> parent who may or may not have clinical signs of M-D (as phenotypic expression in the parent would depend on the gender of the transmitting grandparent). Each child of an individual with <i>SGCE</i>-M-D has a 50% chance of inheriting the pathogenic variant. Almost all children who inherit an <i>SGCE</i> pathogenic variant from their father develop symptoms, whereas only ~5% of children who inherit an <i>SGCE</i> pathogenic variant from their mother develop symptoms. Once the <i>SGCE</i> pathogenic variant has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="myo-dystonia.Diagnosis"><h2 id="_myo-dystonia_Diagnosis_">Diagnosis</h2><div id="myo-dystonia.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>SGCE</i> myoclonus-dystonia (<i>SGCE</i>-M-D) <b>should be suspected</b> in individuals with myoclonus alone or with dystonia that begins in the first or second decade of life. It less frequently presents with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> dystonia. Recently suggested criteria for the diagnosis of M-D require four major criteria and no exclusionary criteria OR three major criteria, two minor criteria, and no exclusionary criteria [<a class="bk_pop" href="#myo-dystonia.REF.roze.2018.484">Roze et al 2018</a>].</p><p><b>Major criteria</b></p><ul><li class="half_rhythm"><div>Myoclonus <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> or predominating over dystonia</div></li><li class="half_rhythm"><div>Prominence of the motor manifestations in the upper body</div></li><li class="half_rhythm"><div>Absence of truncal dystonia</div></li><li class="half_rhythm"><div>Positive family history</div></li><li class="half_rhythm"><div>Onset before age 18 years</div></li></ul><p><b>Minor criteria</b></p><ul><li class="half_rhythm"><div>Obsessive-compulsive disorder, anxiety-related disorder, or alcohol dependence</div></li><li class="half_rhythm"><div>Spontaneous remission of limb dystonia during childhood or adolescence</div></li><li class="half_rhythm"><div>Alcohol responsiveness</div></li></ul><p><b>Exclusionary criteria</b></p><ul><li class="half_rhythm"><div>Other neurologic manifestation in addition to myoclonus and/or dystonia (except seizures, which may be present in some individuals with <i>SGCE</i>-M-D)</div></li><li class="half_rhythm"><div>Abnormal brain MRI examination</div></li><li class="half_rhythm"><div>Neurophysiologic findings that do not support the diagnosis (defined as muscle contractions shorter than 300 ms that can occur in body parts not <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> by dystonia)</div></li></ul></div><div id="myo-dystonia.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>SGCE</i>-M-D <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with myoclonus and/or dystonia by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SGCE</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1414/table/myo-dystonia.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figmyodystoniaTmoleculargenetictesting" rid-ob="figobmyodystoniaTmoleculargenetictesting">Table 1</a>).</p><p>Note: (1) <i>SGCE</i> is maternally <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> and, therefore, expressed only from the paternal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>. While rare cases of maternal inheritance have been reported (see <a href="#myo-dystonia.Penetrance">Penetrance</a> and <a href="#myo-dystonia.Molecular_Genetics">Molecular Genetics</a>), <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals typically have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on the paternal allele. (2) A small number of individuals have been identified with either microdeletions of <i>SGCE</i> or maternal <a class="def" href="/books/n/gene/glossary/def-item/uniparental-disomy/">uniparental disomy</a> resulting in <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> of both <i>SGCE</i> alleles (see <a href="#myo-dystonia.Genetically_Related_Allelic">Genetically Related Disorders</a>).</p><p>Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>. However, for this disorder, a multigene panel that also includes <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> is recommended (see <a class="figpopup" href="/books/NBK1414/table/myo-dystonia.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figmyodystoniaTmoleculargenetictesting" rid-ob="figobmyodystoniaTmoleculargenetictesting">Table 1</a>):</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>SGCE</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications. Single-gene testing is most appropriate in individuals from families with a previously identified <i>SGCE</i> pathogenic variant.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A dystonia <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>SGCE</i> and other genes of interest (see <a href="#myo-dystonia.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder, a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK1414/table/myo-dystonia.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figmyodystoniaTmoleculargenetictesting" rid-ob="figobmyodystoniaTmoleculargenetictesting">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="myo-dystonia.T.molecular_genetic_testing" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>SGCE</i> Myoclonus-Dystonia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1414/table/myo-dystonia.T.molecular_genetic_testing/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__myo-dystonia.T.molecular_genetic_testing_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_myo-dystonia.T.molecular_genetic_testing_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_myo-dystonia.T.molecular_genetic_testing_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_myo-dystonia.T.molecular_genetic_testing_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_myo-dystonia.T.molecular_genetic_testing_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SGCE</i></td><td headers="hd_h_myo-dystonia.T.molecular_genetic_testing_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_myo-dystonia.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~75%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_myo-dystonia.T.molecular_genetic_testing_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_myo-dystonia.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~25%&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="myo-dystonia.TF.1.1"><p class="no_margin">See <a href="/books/NBK1414/#myo-dystonia.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="myo-dystonia.TF.1.2"><p class="no_margin">See <a href="#myo-dystonia.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="myo-dystonia.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="myo-dystonia.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#myo-dystonia.REF.tezenas_du_montcel.2006.394">Tezenas du Montcel et al [2006]</a>, <a class="bk_pop" href="#myo-dystonia.REF.raymond.2008.588">Raymond et al [2008]</a>, <a class="bk_pop" href="#myo-dystonia.REF.roze.2008.1010">Roze et al [2008]</a></p></div></dd><dt>5. </dt><dd><div id="myo-dystonia.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="myo-dystonia.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#myo-dystonia.REF.deberardinis.2003.31">DeBerardinis et al [2003]</a>, <a class="bk_pop" href="#myo-dystonia.REF.asmus.2005.792">Asmus et al [2005]</a>, <a class="bk_pop" href="#myo-dystonia.REF.asmus.2007.2736">Asmus et al [2007]</a>, <a class="bk_pop" href="#myo-dystonia.REF.han.2007.888">Han et al [2007]</a>, <a class="bk_pop" href="#myo-dystonia.REF.gr_newald.2008.331">Gr&#x000fc;newald et al [2008]</a>, <a class="bk_pop" href="#myo-dystonia.REF.ritz.2009.653">Ritz et al [2009]</a>, <a class="bk_pop" href="#myo-dystonia.REF.peall.2014.2296">Peall et al [2014]</a></p></div></dd></dl></div></div></div></div></div><div id="myo-dystonia.Clinical_Characteristics"><h2 id="_myo-dystonia_Clinical_Characteristics_">Clinical Characteristics</h2><div id="myo-dystonia.Clinical_Description"><h3>Clinical Description</h3><p><i>SGCE</i> myoclonus-dystonia (<i>SGCE</i>-M-D) is a movement disorder characterized by a combination of rapid, brief muscle contractions (myoclonus), and/or sustained twisting and repetitive movements that result in abnormal postures (dystonia). Onset is most often in the first decade of life or in adolescence.</p><p>While most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> adults report a dramatic response of myoclonus to ingestion of alcohol [<a class="bk_pop" href="#myo-dystonia.REF.quinn.1996.119">Quinn 1996</a>], the alleviation of findings following alcohol ingestion varies within and between families. Alcohol dependence may be a comorbidity in those who do respond.</p><p>The myoclonic jerks typical of <i>SGCE</i>-M-D are brief, lightning-like movements most often affecting the neck, trunk, and upper limbs, with legs less prominently affected. In children, leg and trunk myoclonus may in rare cases lead to falls [<a class="bk_pop" href="#myo-dystonia.REF.luciano.2009.425">Luciano et al 2009</a>]. Myoclonus is usually the presenting manifestation of <i>SGCE</i>-M-D.</p><p>Approximately half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (54%) have focal or segmental dystonia that manifests as cervical dystonia and/or writer's cramp [<a class="bk_pop" href="#myo-dystonia.REF.asmus.2002.489">Asmus et al 2002</a>, <a class="bk_pop" href="#myo-dystonia.REF.klein.2002.675">Klein et al 2002</a>]. In contrast to primary torsion dystonia [<a class="bk_pop" href="#myo-dystonia.REF.bressman.2000.1746">Bressman et al 2000</a>], dystonia in the lower limbs is rare, although it has been reported in individuals with infantile onset [<a class="bk_pop" href="#myo-dystonia.REF.kyllerman.1990.270">Kyllerman et al 1990</a>]. In addition, the dystonia does not tend to worsen or generalize in the course of the disease. Infrequently, dystonia is the only disease manifestation.</p><p>The involuntary movements are frequently precipitated or worsened by active movements of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> body parts. Other factors eliciting or enhancing the movements include stress [<a class="bk_pop" href="#myo-dystonia.REF.kyllerman.1990.270">Kyllerman et al 1990</a>], sudden noise [<a class="bk_pop" href="#myo-dystonia.REF.asmus.2001.121">Asmus et al 2001</a>, <a class="bk_pop" href="#myo-dystonia.REF.trottenberg.2001.769">Trottenberg et al 2001</a>], caffeine [<a class="bk_pop" href="#myo-dystonia.REF.nygaard.1999.794">Nygaard et al 1999</a>], and tactile stimuli [<a class="bk_pop" href="#myo-dystonia.REF.nygaard.1999.794">Nygaard et al 1999</a>].</p><p>Tremor (postural or other) may be a feature in a subset of individuals [<a class="bk_pop" href="#myo-dystonia.REF.vidailhet.2001.1213">Vidailhet et al 2001</a>].</p><p>Psychiatric comorbidities have been reported. One systematic analysis of 307 participants with pathogenic variants in <i>SGCE</i> and M-D found that 65% had one or more psychiatric diagnoses, the most common of which were specific (33%) and social phobias (31%), followed by alcohol dependence (24%) and obsessive-compulsive disorder (OCD) (21%) [<a class="bk_pop" href="#myo-dystonia.REF.peall.2015.4">Peall et al 2015</a>]. A further comparison of symptomatic and asymptomatic individuals with an <i>SGCE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> reported in this study found that OCD and social phobia were ten and 12 times more likely, respectively, in symptomatic individuals. It is unclear if psychiatric features seen in people with <i>SGCE</i>-M-D are a result of the <i>SGCE</i> pathogenic variant or a consequence of living with the disease. One argument against a purely reactive explanation, however, is that OCD is generally not considered a reactive condition.</p><p>Other neurologic signs and symptoms including dementia and ataxia are rare in <i>SGCE</i>-M-D [<a class="bk_pop" href="#myo-dystonia.REF.gasser.1998.325">Gasser 1998</a>]. Seizures are also rare, but have been reported in at least three families and are no longer considered exclusionary for diagnosis. However, the significance of this finding remains unclear [<a class="bk_pop" href="#myo-dystonia.REF.foncke.2003.1988">Foncke et al 2003</a>, <a class="bk_pop" href="#myo-dystonia.REF.oriordan.2004.1456">O'Riordan et al 2004</a>, <a class="bk_pop" href="#myo-dystonia.REF.haugarvoll.2014.358">Haugarvoll et al 2014</a>].</p><p><i>SGCE</i>-M-D is compatible with an active life of normal span [<a class="bk_pop" href="#myo-dystonia.REF.nygaard.1999.794">Nygaard et al 1999</a>].</p><p>Although spontaneous remission of <i>SGCE</i>-M-D has been reported [<a class="bk_pop" href="#myo-dystonia.REF.roze.2008.1010">Roze et al 2008</a>], <i>SGCE</i>-M-D may also be gradually progressive [<a class="bk_pop" href="#myo-dystonia.REF.trottenberg.2001.769">Trottenberg et al 2001</a>], leading to considerable functional disability and sometimes to early retirement [<a class="bk_pop" href="#myo-dystonia.REF.hjermind.2003.1536">Hjermind et al 2003</a>, <a class="bk_pop" href="#myo-dystonia.REF.mar_chal.2003.114">Mar&#x000e9;chal et al 2003</a>].</p><p>Multiple studies support a different disease mechanism for <i>SGCE</i>-M-D than for <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> dystonia. Currently, the leading hypotheses suggest dysfunction of the cerebello-thalamo-cortical or striato-pallido-thalmo-cortical pathways [<a class="bk_pop" href="#myo-dystonia.REF.popa.2014.612">Popa et al 2014</a>, <a class="bk_pop" href="#myo-dystonia.REF.roze.2015.871">Roze et al 2015</a>].</p></div><div id="myo-dystonia.GenotypePhenotype_Correlati"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been identified.</p></div><div id="myo-dystonia.Penetrance"><h3>Penetrance</h3><p>Reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> on maternal transmission of the disease <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> has been observed, suggesting that maternal <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> of <i>SGCE</i> suppresses expression of the maternally inherited <i>SGCE</i> allele [<a class="bk_pop" href="#myo-dystonia.REF.zimprich.2001.66">Zimprich et al 2001</a>].</p><ul><li class="half_rhythm"><div>Consistent with this hypothesis, two studies demonstrated both paternal transmission of an <i>SGCE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and DNA <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> differences consistent with maternal <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> [<a class="bk_pop" href="#myo-dystonia.REF.m_ller.2002.1303">M&#x000fc;ller et al 2002</a>, <a class="bk_pop" href="#myo-dystonia.REF.grabowski.2003.138">Grabowski et al 2003</a>].</div></li><li class="half_rhythm"><div>Because about 5% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals inherit the <i>SGCE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from their mothers [<a class="bk_pop" href="#myo-dystonia.REF.zimprich.2001.66">Zimprich et al 2001</a>, <a class="bk_pop" href="#myo-dystonia.REF.grabowski.2003.138">Grabowski et al 2003</a>], the apparent suppression of the M-D <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> on maternal transmission of the <i>SGCE</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> is incomplete. In these instances, the phenotype may be milder. The reasons for loss of the maternal imprint are unknown.</div></li></ul></div><div id="myo-dystonia.Nomenclature"><h3>Nomenclature</h3><p>"Myoclonus-dystonia" is the term used for individuals with an <i>SGCE</i>-like <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#myo-dystonia.REF.roze.2018.484">Roze et al 2018</a>]. It is distinguished from "myoclonic dystonia," a condition having a primarily dystonic phenotype with longer duration jerks co-occurring in the dystonic body regions. Additional terms used in the past for <i>SGCE</i>-M-D include "inherited myoclonus-dystonia syndrome," "alcohol-responsive myoclonic dystonia," and "hereditary essential myoclonus" [<a class="bk_pop" href="#myo-dystonia.REF.quinn.1988.391">Quinn et al 1988</a>, <a class="bk_pop" href="#myo-dystonia.REF.quinn.1996.119">Quinn 1996</a>, <a class="bk_pop" href="#myo-dystonia.REF.lang.1997.127">Lang 1997</a>].</p></div><div id="myo-dystonia.Prevalence"><h3>Prevalence</h3><p>Little is known about the prevalence of <i>SGCE</i>-M-D. Tthe disease has been described in families of many nationalities including mixed European, German, Irish, Turkish, Brazilian, and Canadian.</p></div></div><div id="myo-dystonia.Genetically_Related_Allelic"><h2 id="_myo-dystonia_Genetically_Related_Allelic_">Genetically Related (Allelic) Disorders</h2><p>No other <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is known to be associated with intragenic pathogenic variants in <i>SGCE</i>.</p><p><b>Microdeletion 7q21.</b> At least 15 individuals with 7q21 microdeletions have been reported; most have typical symptoms of <i>SGCE</i>-M-D with a variety of additional features including short stature, facial dysmorphism, intrauterine growth deficiency, microcephaly, cognitive impairment, language delay, psychosis, joint laxity, and bone fractures [<a class="bk_pop" href="#myo-dystonia.REF.carecchio.2013.787">Carecchio et al 2013</a>, <a class="bk_pop" href="#myo-dystonia.REF.peall.2014.2296">Peall et al 2014</a>]. Sibs in one family were found to have M-D and cognitive impairment; the father and three of his sibs had adult-onset psychosis with no movement disorder [<a class="bk_pop" href="#myo-dystonia.REF.dale.2011.1774">Dale et al 2011</a>].</p><p>One additional individual with M-D, language delay, <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features, and a seemingly balanced <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> reciprocal <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> was subsequently found to have microdeletions of 7q21 and 9q23 [<a class="bk_pop" href="#myo-dystonia.REF.bonnet.2008.876">Bonnet et al 2008</a>].</p><p><b>Maternal <a class="def" href="/books/n/gene/glossary/def-item/uniparental-disomy/">uniparental disomy</a> (mUPD) of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 7</b> has also been observed in three persons with M-D and <a href="/books/n/gene/rss/">Silver-Russell syndrome</a> (SRS) where M-D is presumably due to <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> of both <i>SGCE</i> alleles [<a class="bk_pop" href="#myo-dystonia.REF.guettard.2008.1380">Guettard et al 2008</a>, <a class="bk_pop" href="#myo-dystonia.REF.stark.2010.2342">Stark et al 2010</a>, <a class="bk_pop" href="#myo-dystonia.REF.sheridan.2013.368">Sheridan et al 2013</a>].</p></div><div id="myo-dystonia.Differential_Diagnosis"><h2 id="_myo-dystonia_Differential_Diagnosis_">Differential Diagnosis</h2><p>Myoclonic dystonia 26 (OMIM <a href="https://omim.org/entry/616398" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616398</a>), associated with <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>KCTD17</i>, is closest in <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> to <i>SGCE</i> myoclonus-dystonia (<i>SGCE</i>-M-D). For further information about myoclonic dystonia 26 and other disorders to consider in the differential diagnosis of <i>SGCE</i>-M-D, see <a class="figpopup" href="/books/NBK1414/table/myo-dystonia.T.other_genes_of_interest_i/?report=objectonly" target="object" rid-figpopup="figmyodystoniaTothergenesofinteresti" rid-ob="figobmyodystoniaTothergenesofinteresti">Table 2</a>.</p><div id="myo-dystonia.T.other_genes_of_interest_i" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Other Genes of Interest in the Differential Diagnosis of <i>SGCE</i> Myoclonus-Dystonia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1414/table/myo-dystonia.T.other_genes_of_interest_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__myo-dystonia.T.other_genes_of_interest_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_2" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Key Clinical Features of Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4" id="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/<i>SGCE</i>-M-D</th><th headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4" id="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from <i>SGCE</i>-M-D</th></tr></thead><tbody><tr><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ADCY5</i></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/adcy5-dysk/"><i>ADCY5</i>-related dyskinesia</a></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Possible cause of <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> M-D&#x000a0;<sup>1</sup></div></li><li class="half_rhythm"><div>Often childhood onset&#x000a0;<sup>2</sup></div></li></ul>
</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Typically associated w/additional features (e.g., chorea, early motor delay, alternating hemiplegia of childhood)</td></tr><tr><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATM</i></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant <a href="/books/n/gene/ataxia-telangiectas/">ataxia-telangiectasia</a>&#x000a0;<sup>3</sup></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dystonia only or dystonia w/myoclonus may be present.</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Observed in Mennonite families of Russian origin</div></li><li class="half_rhythm"><div>High cancer frequency &#x00026; adverse responses to chemotherapeutic agents associated w/a common <i>ATM</i> haplotype &#x00026; homozygosity for c.6200C&#x0003e;A</div></li></ul>
</td></tr><tr><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATN1</i></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/drpla/">DRPLA</a></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Myoclonus, epilepsy</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In children:
<ul><li class="half_rhythm"><div>Ataxia</div></li><li class="half_rhythm"><div>Progressive intellectual deterioration</div></li></ul>
In adults:
<ul><li class="half_rhythm"><div>Ataxia</div></li><li class="half_rhythm"><div>Choreoathetosis</div></li><li class="half_rhythm"><div>Dementia or character changes</div></li></ul>
</td></tr><tr><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATP7B</i></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/wilson/">Wilson disease</a></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dystonia</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Biochemical findings: &#x02193; serum copper &#x00026; ceruloplasmin concentrations; &#x02191; urinary copper excretion</div></li><li class="half_rhythm"><div>Kayser-Fleischer corneal ring</div></li></ul>
</td></tr><tr><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATXN3</i></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sca3/">Spinocerebellar ataxia type 3</a></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dystonia in 1 individual</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cerebellar ataxia, pyramidal signs, pontocerebellar atrophy</td></tr><tr><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CSTB</i></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/epm1/">Unverricht-Lundborg disease</a></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Myoclonus, seizures</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Ataxia, incoordination, intentional tremor, &#x00026; dysarthria</div></li><li class="half_rhythm"><div>Emotional lability, depression, &#x00026; mild &#x02193; in intellectual performance over time</div></li></ul>
</td></tr><tr><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EPM2A</i><br /><i>NHLRC1</i></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/lafora/">Progressive myoclonus epilepsy, Lafora type</a></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Myoclonus, seizures</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>&#x02191; frequency &#x00026; intractability of seizures</div></li><li class="half_rhythm"><div>Cognitive decline apparent at or soon after onset of seizures</div></li><li class="half_rhythm"><div>Dysarthria &#x00026; ataxia appear early; spasticity appears late.</div></li></ul>
</td></tr><tr><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GCH1</i></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/drd/">GTP cyclohydrolase 1-deficient dopa-responsive dystonia</a></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">M-D in 1 individual&#x000a0;<sup>4</sup></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Dramatic &#x00026; sustained response to levodopa</div></li><li class="half_rhythm"><div>Typically presents w/gait disturbance, later development of parkinsonism, &#x00026; diurnal fluctuation of symptoms</div></li></ul>
</td></tr><tr><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GNB1</i></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GNB1</i> myoclonic dystonia</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">M-D in 1 individual w/comorbid OCD,&#x000a0;<sup>5</sup> dystonia in some (46 individuals)&#x000a0;<sup>6</sup></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In individuals w/M-D:
<ul><li class="half_rhythm"><div>Mild ID</div></li><li class="half_rhythm"><div>Limited upgaze</div></li><li class="half_rhythm"><div>Hypotonia</div></li></ul>
In others w/dystonia:
<ul><li class="half_rhythm"><div>Abnormal MRI</div></li><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>Developmental &#x00026; growth delay</div></li><li class="half_rhythm"><div>Genitourinary &#x00026; gastrointestinal abnormality</div></li><li class="half_rhythm"><div>Vision, hearing, cardiac, &#x00026; hematologic abnormalities</div></li></ul>
</td></tr><tr><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCTD17</i></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Myoclonic dystonia 26 (OMIM <a href="https://omim.org/entry/616398" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616398</a>)</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early-onset myoclonic jerks; development of dystonia later in life (in 4 individuals)</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early motor delay, severe lingual dystonia, &#x00026; mild cognitive delay in 2 families w/splice variants&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">mtDNA</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/merrf/">MERRF</a></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mat</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Myoclonus; seizures</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ataxia &#x00026; ragged red fibers on muscle biopsy</td></tr><tr><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NKX2-1</i>&#x000a0;<sup>8</sup></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Benign hereditary chorea (OMIM <a href="https://omim.org/entry/118700" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">118700</a>)</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Myoclonus</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Does not demonstrate aggravation of jerks w/complex motor tasks (in contrast to action-induced myoclonus of M-D)</td></tr><tr><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PRKCG</i></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sca14/">Spinocerebellar ataxia type 14</a></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">M-D in 1 individual&#x000a0;<sup>9</sup></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Slowly progressive cerebellar ataxia, dysarthria, &#x00026; nystagmus</td></tr><tr><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RELN</i></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RELN</i> myoclonus-dystonia&#x000a0;<sup>7</sup></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Seemingly typical adult-onset M-D reported in 3 families &#x00026; 2 <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases</div></li><li class="half_rhythm"><div>Alcohol responsiveness &#x00026; psychiatric comorbidities (5 individuals)&#x000a0;<sup>10</sup></div></li></ul>
</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Mean onset: age 22 yrs</div></li><li class="half_rhythm"><div>Latest onset: age 53 yrs</div></li></ul>
</td></tr><tr><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TOR1A</i></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/dystonia/">DYT1 early-onset isolated dystonia</a></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unusual presentation of alcohol-responsive M-D in 1 individual&#x000a0;<sup>11</sup></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cervical dystonia is uncommon in DYT1 dystonia.</td></tr><tr><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TTPA</i></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/aved/">Ataxia with vitamin E deficiency</a></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dystonia</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>1st symptoms incl progressive ataxia, clumsiness of hands, loss of proprioception, &#x00026; areflexia</div></li><li class="half_rhythm"><div>Cerebellar atrophy</div></li></ul>
</td></tr><tr><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TUBB2B</i></td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TUBB2B</i> tubulinopathy (mild form)&#x000a0;<sup>12</sup><br />(see <a href="/books/n/gene/tubulin-ov/">Tubulinopathies Overview</a>)</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">M-D in 1 individual</td><td headers="hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_1_4 hd_h_myo-dystonia.T.other_genes_of_interest_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Mild cognitive impairment &#x00026; skeletal anomalies</div></li><li class="half_rhythm"><div>Asymmetric pachygyria &#x00026; <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> basal ganglia on neuroimaging&#x000a0;<sup>12</sup></div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; ID = intellectual disability; Mat = maternal inheritance; M-D = myoclonus-dystonia; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt>1. </dt><dd><div id="myo-dystonia.TF.2.1"><p class="no_margin"><a class="bk_pop" href="#myo-dystonia.REF.douglas.2017.111">Douglas et al [2017]</a></p></div></dd><dt>2. </dt><dd><div id="myo-dystonia.TF.2.2"><p class="no_margin"><a class="bk_pop" href="#myo-dystonia.REF.chen.2015.2026">Chen et al [2015]</a></p></div></dd><dt>3. </dt><dd><div id="myo-dystonia.TF.2.3"><p class="no_margin"><a class="bk_pop" href="#myo-dystonia.REF.saunderspullman.2012.649">Saunders-Pullman et al [2012]</a>, <a class="bk_pop" href="#myo-dystonia.REF.levy.2018.1238">Levy &#x00026; Lang [2018]</a></p></div></dd><dt>4. </dt><dd><div id="myo-dystonia.TF.2.4"><p class="no_margin"><a class="bk_pop" href="#myo-dystonia.REF.leuzzi.2002.1241">Leuzzi et al [2002]</a></p></div></dd><dt>5. </dt><dd><div id="myo-dystonia.TF.2.5"><p class="no_margin"><a class="bk_pop" href="#myo-dystonia.REF.jones.2019.1079">Jones et al [2019]</a></p></div></dd><dt>6. </dt><dd><div id="myo-dystonia.TF.2.6"><p class="no_margin"><a class="bk_pop" href="#myo-dystonia.REF.petrovski.2016.1001">Petrovski et al [2016]</a>, <a class="bk_pop" href="#myo-dystonia.REF.steinr_cke.2016.e106">Steinr&#x000fc;cke et al [2016]</a>, <a class="bk_pop" href="#myo-dystonia.REF.lohmann.2017.1078">Lohmann et al [2017]</a>, <a class="bk_pop" href="#myo-dystonia.REF.hemati.2018.2259">Hemati et al [2018]</a></p></div></dd><dt>7. </dt><dd><div id="myo-dystonia.TF.2.7"><p class="no_margin"><a class="bk_pop" href="#myo-dystonia.REF.mencacci.2015.938">Mencacci et al [2015]</a>, <a class="bk_pop" href="#myo-dystonia.REF.graziola.2019.4">Graziola et al [2019]</a>, <a class="bk_pop" href="#myo-dystonia.REF.marc_grau.2019.7">Marc&#x000e9;-Grau et al [2019]</a></p></div></dd><dt>8. </dt><dd><div id="myo-dystonia.TF.2.8"><p class="no_margin">Because of the association of hypothyroidism with pathogenic variants in <i>NKX2-1</i>, thyroid hormone screening should be considered in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. See OMIM <a href="https://omim.org/entry/118700" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">118700</a>, <a href="https://omim.org/entry/610978" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">610978</a>, <a href="https://omim.org/entry/600635" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">600635</a>.</p></div></dd><dt>9. </dt><dd><div id="myo-dystonia.TF.2.9"><p class="no_margin"><a class="bk_pop" href="#myo-dystonia.REF.foncke.2010.288">Foncke et al [2010]</a></p></div></dd><dt>10. </dt><dd><div id="myo-dystonia.TF.2.10"><p class="no_margin"><a class="bk_pop" href="#myo-dystonia.REF.groen.2015.415">Groen et al [2015]</a></p></div></dd><dt>11. </dt><dd><div id="myo-dystonia.TF.2.11"><p class="no_margin">A male with alcohol-responsive M-D who had the typical three-<a class="def" href="/books/n/gene/glossary/def-item/base-pair/">base pair</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in <i>TOR1A</i> and no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SGCE</i> was reported [<a class="bk_pop" href="#myo-dystonia.REF.tezenas_du_montcel.2006.394">Tezenas du Montcel et al 2006</a>]. His mother was <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> and had only writer's cramp.</p></div></dd><dt>12. </dt><dd><div id="myo-dystonia.TF.2.12"><p class="no_margin"><a class="bk_pop" href="#myo-dystonia.REF.geiger.2017.216">Geiger et al [2017]</a></p></div></dd></dl></div></div></div><p><b>Myoclonic dystonia 15</b> (OMIM <a href="https://omim.org/entry/607488" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">607488</a>). A clinically similar M-D <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in a large Canadian family without an identifiable <i>SGCE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> showed significant evidence for linkage to markers on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 18p (<a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> DYT15) [<a class="bk_pop" href="#myo-dystonia.REF.grimes.2002.1183">Grimes et al 2002</a>, <a class="bk_pop" href="#myo-dystonia.REF.han.2007.888">Han et al 2007</a>]. The M-D phenotype of two other families may also be linked to this chromosome region [<a class="bk_pop" href="#myo-dystonia.REF.sch_le.2004.1181">Sch&#x000fc;le et al 2004</a>]. The overall contribution of this locus to M-D cannot be determined until the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is identified.</p><p>For a review of various genetic and secondary forms of dystonia, see <a href="/books/n/gene/dystonia-ov/">Hereditary Dystonia Overview</a>.</p></div><div id="myo-dystonia.Management"><h2 id="_myo-dystonia_Management_">Management</h2><div id="myo-dystonia.Evaluations_Following_Initi"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with <i>SGCE</i> myoclonus-dystonia (<i>SGCE</i>-M-D) the following evaluations (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><ul><li class="half_rhythm"><div>Clinical examination to evaluate the location, severity, and progression of dystonia and the severity and progression of myoclonus. This is best done by a neurologic specialist in movement disorders.</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="myo-dystonia.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Medications</b> may improve myoclonus and/or dystonia:</p><ul><li class="half_rhythm"><div class="half_rhythm">While multiple antiepileptic medications have been reported in case series or individual reports, zonisamide is the first to demonstrate class I evidence of improvement of both myoclonus and dystonia in a double-blind study [<a class="bk_pop" href="#myo-dystonia.REF.hainque.2016.1729">Hainque et al 2016</a>].</div><div class="half_rhythm">Valproate and levetiracetam may also be used. Topiramate and carbamazepine have been reported to improve myoclonus [<a class="bk_pop" href="#myo-dystonia.REF.nygaard.1999.794">Nygaard et al 1999</a>, <a class="bk_pop" href="#myo-dystonia.REF.sanjari_moghaddam.2018.116">Sanjari Moghaddam et al 2018</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Benzodiazepines, particularly clonazepam, improve mostly myoclonus and tremor [<a class="bk_pop" href="#myo-dystonia.REF.goetz.2001.129">Goetz &#x00026; Horn 2001</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Anticholinergic medication may improve dystonia [<a class="bk_pop" href="#myo-dystonia.REF.goetz.2001.129">Goetz &#x00026; Horn 2001</a>] and botulinum toxin injection may be especially helpful for cervical dystonia [<a class="bk_pop" href="#myo-dystonia.REF.berardelli.2002.s70">Berardelli &#x00026; Curra 2002</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Improvement of dystonia with L-5-hydroxytryptophan has been reported [<a class="bk_pop" href="#myo-dystonia.REF.scheidtmann.2000.839">Scheidtmann et al 2000</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Improvement with both L-dopa [<a class="bk_pop" href="#myo-dystonia.REF.luciano.2009.425">Luciano et al 2009</a>] and the dopamine-depleting medication tetrabenazine has been reported [<a class="bk_pop" href="#myo-dystonia.REF.luciano.2014.1423">Luciano et al 2014</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">One individual with <i>SGCE</i>-M-D who represented a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence of M-D in the family) showed a robust response to zolpidem [<a class="bk_pop" href="#myo-dystonia.REF.park.2009.2172">Park et al 2009</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Gamma-hydroxybutyrate [<a class="bk_pop" href="#myo-dystonia.REF.priori.2000.1706">Priori et al 2000</a>] and sodium oxybate may improve myoclonus [<a class="bk_pop" href="#myo-dystonia.REF.frucht.2005.1330">Frucht et al 2005</a>].</div></li></ul><p>Note: Although the symptoms of <i>SGCE</i>-M-D usually resolve with ingestion of alcohol, the risk of long-term addiction to alcohol renders it an unacceptable treatment option.</p><p><b>Deep brain stimulation (DBS).</b> Studies of globus pallidus interna (Gpi) and/or ventral intermediate nucleus of the thalamus (VIM) DBS in individuals with M-D determined that both were effective long-term treatments, although GPi is now the more frequently chosen target. Marked improvement in both myoclonus and dystonia as well as good quality of life and social adjustment were seen in a cohort of nine individuals with <i>SGCE</i>-M-D who had GPi DBS for at least five years [<a class="bk_pop" href="#myo-dystonia.REF.kosutzka.2019.87">Kosutzka et al 2019</a>]. In individuals with a predominant myoclonus <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> undergoing VIM DBS (3 individuals with <i>SGCE</i> M-D; 2 individuals without an <i>SGCE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>), sustained improvement of both myoclonus and dystonia was found over 50 months [<a class="bk_pop" href="#myo-dystonia.REF.zhang.2019.e933">Zhang et al 2019</a>].</p><p>Stereotactic thalamotomy can improve myoclonus, but caused dysarthria in one individual and mild hemiparesis in another [<a class="bk_pop" href="#myo-dystonia.REF.gasser.1996.363">Gasser et al 1996</a>]. In two others, myoclonus improved, but without significant gain in function [<a class="bk_pop" href="#myo-dystonia.REF.suchowersky.2000.332">Suchowersky et al 2000</a>].</p></div><div id="myo-dystonia.Prevention_of_Secondary_Com"><h3>Prevention of Secondary Complications</h3><p>As self-treatment with alcohol is common, proper treatment and counseling regarding alcohol abuse may decrease alcohol-related toxicities, particularly in adolescents.</p></div><div id="myo-dystonia.Surveillance"><h3>Surveillance</h3><div id="myo-dystonia.T.recommended_surveillance" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with Myoclonus-Dystonia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1414/table/myo-dystonia.T.recommended_surveillance/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__myo-dystonia.T.recommended_surveillance_lrgtbl__"><table><thead><tr><th id="hd_h_myo-dystonia.T.recommended_surveillance_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_myo-dystonia.T.recommended_surveillance_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_myo-dystonia.T.recommended_surveillance_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_myo-dystonia.T.recommended_surveillance_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_myo-dystonia.T.recommended_surveillance_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neurologic examination to assess burden of myoclonus &#x00026; dystonia &#x00026; review therapy &#x00026; side effects</td><td headers="hd_h_myo-dystonia.T.recommended_surveillance_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually</td></tr><tr><td headers="hd_h_myo-dystonia.T.recommended_surveillance_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Psychiatric</b></td><td headers="hd_h_myo-dystonia.T.recommended_surveillance_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation for psychiatric features</td><td headers="hd_h_myo-dystonia.T.recommended_surveillance_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually</td></tr></tbody></table></div></div></div><div id="myo-dystonia.AgentsCircumstances_to_Avoi"><h3>Agents/Circumstances to Avoid</h3><p>Use of alcohol to ameliorate symptoms should be avoided due to the risk of alcohol dependence.</p></div><div id="myo-dystonia.Evaluation_of_Relatives_at"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#myo-dystonia.Related_Genetic_Counseling">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="myo-dystonia.Pregnancy_Management"><h3>Pregnancy Management</h3><p>There is concern about teratogenicity with certain antiepileptic medications that are sometimes used in the treatment of myoclonus-dystonia. These should be avoided in women considering pregnancy or who are known to be pregnant. Discussion of the risks and benefits of using a given antiepileptic drug during pregnancy should ideally take place prior to conception. Women with M-D should be counseled about abstaining from alcohol during pregnancy, particularly during the first trimester, as alcohol negatively affects fetal development.</p><p>See <a href="http://www.mothertobaby.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MotherToBaby</a> for further information on medication use during pregnancy.</p></div><div id="myo-dystonia.Therapies_Under_Investigati"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="myo-dystonia.Genetic_Counseling"><h2 id="_myo-dystonia_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="myo-dystonia.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>SGCE</i> myoclonus-dystonia (<i>SGCE</i>-M-D) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner with <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> determined by the parental origin of the altered <i>SGCE</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>. An <i>SGCE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on the paternally derived (expressed) <i>SGCE</i> allele generally results in disease; a pathogenic variant on the maternally derived (silenced) <i>SGCE</i> allele typically does not result in disease.</p></div><div id="myo-dystonia.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed with <i>SGCE</i>-M-D inherited a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> parent who may or may not have clinical signs of M-D. Because <i>SGCE</i>-M-D shows reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, the parent of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual may have the pathogenic <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> without showing clinical signs [<a class="bk_pop" href="#myo-dystonia.REF.m_ller.2002.1303">M&#x000fc;ller et al 2002</a>, <a class="bk_pop" href="#myo-dystonia.REF.hedrich.2004.1229">Hedrich et al 2004</a>, <a class="bk_pop" href="#myo-dystonia.REF.kock.2004.231">Kock et al 2004</a>, <a class="bk_pop" href="#myo-dystonia.REF.gerrits.2009.178">Gerrits et al 2009</a>]. The mechanism of reduced penetrance is related to maternal <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> and, therefore, based on the parental origin of the pathogenic variant. In general, maternally derived alleles are silenced and paternally derived <i>SGCE</i> alleles are expressed.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with M-D may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>SGCE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#myo-dystonia.REF.hedrich.2004.1229">Hedrich et al 2004</a>, <a class="bk_pop" href="#myo-dystonia.REF.asmus.2007.2736">Asmus et al 2007</a>, <a class="bk_pop" href="#myo-dystonia.REF.borges.2007.1208">Borges et al 2007</a>]; to date only three <i>de novo</i> cases have been reported.</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who appears to represent a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family). Since the <i>SGCE</i> variant was likely inherited from the father, it may be appropriate to evaluate the father first.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Though theoretically possible, no instances of germline mosaicism have been reported.</div></li><li class="half_rhythm"><div>Although most individuals diagnosed with M-D inherited the pathogenic <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> from a parent, the family history may appear to be negative because of either the effects of <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> or failure to recognize the disorder in family members. Since it is possible for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family members to self-medicate with alcohol, a family history of alcoholism may be indicative of additional affected relatives. Therefore, an apparently negative family history cannot be confirmed unless appropriate <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of a proband depends on the genetic status of the parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs of inheriting the pathogenic <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> is 50%. Expression of the pathogenic <i>SGCE</i> allele is influenced by the gender of the parent transmitting the allele (<a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a>).</div><ul><li class="half_rhythm"><div>If the <i>SGCE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is inherited from the father, it is typically expressed and most often the offspring is symptomatic.</div></li><li class="half_rhythm"><div>If the <i>SGCE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is inherited from the mother, most often it is not expressed and the child remains symptom-free. However, about 5% of individuals who inherit the pathogenic variant from their mother do develop symptoms, indicating that the apparent suppression of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> by maternal inheritance of a pathogenic <i>SGCE</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> is incomplete and loss of the maternal imprint occurs at a low frequency. Symptoms in individuals who have a maternally derived <i>SGCE</i> pathogenic variant may be milder than in those who inherit the pathogenic variant from their fathers.</div></li></ul></li><li class="half_rhythm"><div>Because of intrafamilial clinical variability, symptomatic sibs may be more or less severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> than the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> and have different M-D-related findings.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a known <i>SGCE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that cannot be detected in the leukocyte DNA of either parent, the risk to sibs of inheriting a pathogenic variant is estimated to be 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#myo-dystonia.REF.rahbari.2016.126">Rahbari et al 2016</a>].</div></li><li class="half_rhythm"><div>If the parents have not been tested for the <i>SGCE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but are clinically unaffected, sibs are still presumed to be at increased risk for <i>SGCE</i>-M-D because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> parent or the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <i>SGCE</i>-M-D has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><ul><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is male, it is likely that all of his children who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will develop symptoms.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is female, about 5% of her children who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will develop symptoms.</div></li><li class="half_rhythm"><div>Symptomatic offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> may be more or less severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> than the proband.</div></li></ul><p><b>Other family members.</b> The risk to other family members depends on the genetic status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or is known to have an <i>SGCE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members are at risk.</p></div><div id="myo-dystonia.Related_Genetic_Counseling"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul></div><div id="myo-dystonia.Prenatal_Testing_and_Preimp"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>SGCE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible. The results of prenatal testing are not useful in predicting age of onset, severity, type of symptoms, or rate of progression of <i>SGCE</i>-M-D.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="myo-dystonia.Resources"><h2 id="_myo-dystonia_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Dystonia Medical Research Foundation</b></div><div>One East Wacker Drive</div><div>Suite 1730</div><div>Chicago IL 60601-1905</div><div><b>Phone:</b> 800-377-3978 (toll-free); 312-755-0198</div><div><b>Fax:</b> 312-803-0138</div><div><b>Email:</b> dystonia@dystonia-foundation.org</div><div><a href="http://www.dystonia-foundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.dystonia-foundation.org</a></div></li><li class="half_rhythm"><div><b>Dystonia Society</b></div><div>89 Albert Embankment</div><div>3rd Floor</div><div>London SE1 7TP</div><div>United Kingdom</div><div><b>Phone:</b> 0845 458 6211; 0845 458 6322 (Helpline)</div><div><b>Fax:</b> 0845 458 6311</div><div><b>Email:</b> support@dystonia.org.uk</div><div><a href="http://www.dystonia.org.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.dystonia.org.uk</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Dystonias-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Dystonias Information Page</a></div></li><li class="half_rhythm"><div><b>Global Dystonia Registry</b></div><div><a href="http://www.globaldystoniaregistry.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.globaldystoniaregistry.org</a></div></li></ul></div><div id="myo-dystonia.Molecular_Genetics"><h2 id="_myo-dystonia_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="myo-dystonia.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>SGCE Myoclonus-Dystonia: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1414/table/myo-dystonia.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__myo-dystonia.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_myo-dystonia.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_myo-dystonia.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_myo-dystonia.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_myo-dystonia.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_myo-dystonia.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_myo-dystonia.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_myo-dystonia.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/8910" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SGCE</i></a></td><td headers="hd_b_myo-dystonia.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=8910" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">7q21<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_myo-dystonia.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O43556" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Epsilon-sarcoglycan</a></td><td headers="hd_b_myo-dystonia.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/SGCE" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SGCE homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_myo-dystonia.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SGCE" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SGCE</a></td><td headers="hd_b_myo-dystonia.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SGCE[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SGCE</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="myo-dystonia.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="myo-dystonia.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for SGCE Myoclonus-Dystonia (<a href="/omim/159900,604149" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1414/table/myo-dystonia.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__myo-dystonia.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/159900" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">159900</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DYSTONIA 11, MYOCLONIC; DYT11</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/604149" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">604149</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SARCOGLYCAN, EPSILON; SGCE</td></tr></tbody></table></div></div><p>The sarcoglycan <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> family includes alpha, beta, gamma, delta, epsilon, and zeta sarcoglycans. In muscles, these genes encode transmembrane components of the dystrophin-glycoprotein complex, which link the cytoskeleton to the extracellular matrix. <i>SGCE</i> encodes epsilon-sarcoglycan, which is widely expressed in many tissues of the body [<a class="bk_pop" href="#myo-dystonia.REF.ettinger.1997.32534">Ettinger et al 1997</a>, <a class="bk_pop" href="#myo-dystonia.REF.mcnally.1998.27">McNally et al 1998</a>] including various regions of the brain both during development and adulthood [<a class="bk_pop" href="#myo-dystonia.REF.ritz.2011.438">Ritz et al 2011</a>, <a class="bk_pop" href="#myo-dystonia.REF.xiao.2017.52">Xiao et al 2017</a>]. The function of epsilon-sarcoglycan in the brain is unknown.</p><p><i>SGCE</i> comprises 13 exons; <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 10 is differentially spliced and absent from most transcripts, exon 11b is brain specific, and exon 8 is rarely expressed in the brain. Other alternatively spliced exons have been noted but account for &#x0003e;1% of transcripts [<a class="bk_pop" href="#myo-dystonia.REF.ritz.2011.438">Ritz et al 2011</a>]. See <a href="/books/NBK1414/#myo-dystonia.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p><b>Mechanism of disease causation.</b> It is speculated that because maternal <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> transcriptionally silences <i>SGCE</i> and the vast majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals inherit their disease <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> from their fathers, the disease is caused by loss of function of this protein. However, about 5% of affected individuals inherit their abnormal allele from their mothers and presumably also express the wild type allele from their fathers. Therefore, the mechanism of disease pathogenesis is not entirely clear.</p><p>More than 100 pathogenic variants in <i>SGCE</i> have been reported in HGMD (see <a href="/books/NBK1414/#myo-dystonia.molgen.TA">Table A</a>, <b>Genes and Databases</b>). Reported pathogenic variants include <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, deletions, and insertions leading to frame shifts and <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> errors as well as <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions [<a class="bk_pop" href="#myo-dystonia.REF.zimprich.2001.66">Zimprich et al 2001</a>, <a class="bk_pop" href="#myo-dystonia.REF.asmus.2002.489">Asmus et al 2002</a>, <a class="bk_pop" href="#myo-dystonia.REF.doheny.2002.1187">Doheny et al 2002</a>, <a class="bk_pop" href="#myo-dystonia.REF.klein.2002.675">Klein et al 2002</a>, <a class="bk_pop" href="#myo-dystonia.REF.m_ller.2002.1303">M&#x000fc;ller et al 2002</a>, <a class="bk_pop" href="#myo-dystonia.REF.deberardinis.2003.31">DeBerardinis et al 2003</a>, <a class="bk_pop" href="#myo-dystonia.REF.foncke.2003.1988">Foncke et al 2003</a>, <a class="bk_pop" href="#myo-dystonia.REF.han.2003.244">Han et al 2003</a>, <a class="bk_pop" href="#myo-dystonia.REF.hjermind.2003.1536">Hjermind et al 2003</a>, <a class="bk_pop" href="#myo-dystonia.REF.mar_chal.2003.114">Mar&#x000e9;chal et al 2003</a>, <a class="bk_pop" href="#myo-dystonia.REF.hedrich.2004.1229">Hedrich et al 2004</a>, <a class="bk_pop" href="#myo-dystonia.REF.kock.2004.231">Kock et al 2004</a>, <a class="bk_pop" href="#myo-dystonia.REF.sch_le.2004.1181">Sch&#x000fc;le et al 2004</a>, <a class="bk_pop" href="#myo-dystonia.REF.asmus.2005.792">Asmus et al 2005</a>, <a class="bk_pop" href="#myo-dystonia.REF.valente.2005.737">Valente et al 2005</a>, <a class="bk_pop" href="#myo-dystonia.REF.asmus.2007.2736">Asmus et al 2007</a>, <a class="bk_pop" href="#myo-dystonia.REF.han.2007.888">Han et al 2007</a>, <a class="bk_pop" href="#myo-dystonia.REF.gr_newald.2008.331">Gr&#x000fc;newald et al 2008</a>, <a class="bk_pop" href="#myo-dystonia.REF.ritz.2009.653">Ritz et al 2009</a>].</p><p>Gene deletions in <i>SGCE</i> also cause M-D usually with other features (see 7q21 microdeletions) [<a class="bk_pop" href="#myo-dystonia.REF.carecchio.2013.787">Carecchio et al 2013</a>, <a class="bk_pop" href="#myo-dystonia.REF.peall.2014.2296">Peall et al 2014</a>].</p><p>Of note, while only about 50% of individuals with clinical features of M-D are found to have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SGCE</i>, the detection rate increases when paternal transmission is recognized [<a class="bk_pop" href="#myo-dystonia.REF.ritz.2009.653">Ritz et al 2009</a>].</p></div><div id="myo-dystonia.References"><h2 id="_myo-dystonia_References_">References</h2><div id="myo-dystonia.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.asmus.2007.2736">Asmus F, Hjermind LE, Dupont E, Wagenstaller J, Haberlandt E, Munz M, Strom TM, Gasser T. Genomic deletion size at the epsilon-sarcoglycan locus determines the clinical phenotype. <span><span class="ref-journal">Brain. </span>2007;<span class="ref-vol">130</span>:2736–45.</span> [<a href="/pubmed/17898012" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17898012</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.asmus.2005.792">Asmus F, Salih F, Hjermind LE, Ostergaard K, Munz M, K&#x000fc;hn AA, Dupont E, Kupsch A, Gasser T. Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene. <span><span class="ref-journal">Ann Neurol. </span>2005;<span class="ref-vol">58</span>:792–7.</span> [<a href="/pubmed/16240355" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16240355</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.asmus.2001.121">Asmus F, Zimprich A, Naumann M, Berg D, Bertram M, Ceballos-Baumann A, Pruszak-Seel R, Kabus C, Dichgans M, Fuchs S, Muller-Myhsok B, Gasser T. Inherited myoclonus-dystonia syndrome: narrowing the 7q21-q31 locus in German families. <span><span class="ref-journal">Ann Neurol. </span>2001;<span class="ref-vol">49</span>:121–4.</span> [<a href="/pubmed/11198282" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11198282</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.asmus.2002.489">Asmus F, Zimprich A, Tezenas Du Montcel S, Kabus C, Deuschl G, Kupsch A, Ziemann U, Castro M, Kuhn AA, Strom TM, Vidailhet M, Bhatia KP, Durr A, Wood NW, Brice A, Gasser T. Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype. <span><span class="ref-journal">Ann Neurol. </span>2002;<span class="ref-vol">52</span>:489–92.</span> [<a href="/pubmed/12325078" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12325078</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.berardelli.2002.s70">Berardelli A, Curra A. Pathophysiology and treatment of cranial dystonia. <span><span class="ref-journal">Mov Disord. </span>2002;<span class="ref-vol">17</span> Suppl 2:S70–4.</span> [<a href="/pubmed/11836760" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11836760</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.bonnet.2008.876">Bonnet C, Gr&#x000e9;goire MJ, Vibert M, Raffo E, Leheup B, Jonveaux P. Cryptic 7q21 and 9p23 deletions in a patient with apparently balanced de novo reciprocal translocation t(7;9)(q21;p23) associated with a dystonia-plus syndrome: paternal deletion of the epsilon-sarcoglycan (SGCE) gene. <span><span class="ref-journal">J Hum Genet. </span>2008;<span class="ref-vol">53</span>:876–85.</span> [<a href="/pubmed/18651096" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18651096</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.borges.2007.1208">Borges V, Aguiar Pde C, Ferraz HB, Ozelius LJ. Novel and de novo mutations of the SGCE gene in Brazilian patients with myoclonus-dystonia. <span><span class="ref-journal">Mov Disord. </span>2007;<span class="ref-vol">22</span>:1208–9.</span> [<a href="/pubmed/17394244" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17394244</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.bressman.2000.1746">Bressman SB, Sabatti C, Raymond D, de Leon D, Klein C, Kramer PL, Brin MF, Fahn S, Breakefield X, Ozelius LJ, Risch NJ. The DYT1 phenotype and guidelines for diagnostic testing. <span><span class="ref-journal">Neurology. </span>2000;<span class="ref-vol">54</span>:1746–52.</span> [<a href="/pubmed/10802779" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10802779</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.carecchio.2013.787">Carecchio M, Magliozzi M, Copetti M, Ferraris A, Bernardini L, Bonetti M, Defazio G, Edwards MJ, Torrente I, Pellegrini F, Comi C, Bhatia KP, Valente EM. Defining the epsilon-sarcoglycan (SGCE) gene phenotypic signature in myoclonus-dystonia: a reappraisal of genetic testing criteria. <span><span class="ref-journal">Mov Disord. </span>2013;<span class="ref-vol">28</span>:787–94.</span> [<a href="/pubmed/23677909" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23677909</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.chen.2015.2026">Chen DH, M&#x000e9;neret A, Friedman JR, Korvatska O, Gad A, Bonkowski ES, Stessman HA, Doummar D, Mignot C, Anheim M, Bernes S, Davis MY, Damon-Perri&#x000e8;re N, Degos B, Grabli D, Gras D, Hisama FM, Mackenzie KM, Swanson PD, Tranchant C, Vidailhet M, Winesett S, Trouillard O, Amendola LM, Dorschner MO, Weiss M, Eichler EE, Torkamani A, Roze E, Bird TD, Raskind WH. ADCY5-related dyskinesia: broader spectrum and genotype-phenotype correlations. <span><span class="ref-journal">Neurology. </span>2015;<span class="ref-vol">85</span>:2026–35.</span> [<a href="/pmc/articles/PMC4676753/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4676753</span></a>] [<a href="/pubmed/26537056" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26537056</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.dale.2011.1774">Dale RC, Nasti JJ, Peters GB. Familial 7q21.3 microdeletion involving epsilon-sarcoglycan causing myoclonus dystonia, cognitive impairment, and psychosis. <span><span class="ref-journal">Mov Disord. </span>2011;<span class="ref-vol">26</span>:1774–5.</span> [<a href="/pubmed/21425342" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21425342</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.deberardinis.2003.31">DeBerardinis RJ, Conforto D, Russell K, Kaplan J, Kollros PR, Zackai EH, Emanuel BS. Myoclonus in a patient with a deletion of the epsilon-sarcoglycan locus on chromosome 7q21. <span><span class="ref-journal">Am J Med Genet. </span>2003;<span class="ref-vol">121A</span>:31–6.</span> [<a href="/pubmed/12900898" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12900898</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.doheny.2002.1187">Doheny DO, Brin MF, Morrison CE, Smith CJ, Walker RH, Abbasi S, Muller B, Garrels J, Liu L, De Carvalho Aguiar P, Schilling K, Kramer P, De Leon D, Raymond D, Saunders-Pullman R, Klein C, Bressman SB, Schmand B, Tijssen MA, Ozelius LJ, Silverman JM. Phenotypic features of myoclonus-dystonia in three kindreds. <span><span class="ref-journal">Neurology. </span>2002;<span class="ref-vol">59</span>:1187–96.</span> [<a href="/pubmed/12391346" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12391346</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.douglas.2017.111">Douglas AG, Andreoletti G, Talbot K, Hammans SR, Singh J, Whitney A, Ennis S, Foulds NC. ADCY5-related dyskinesia presenting as familial myoclonus-dystonia. <span><span class="ref-journal">Neurogenetics. </span>2017;<span class="ref-vol">18</span>:111–7.</span> [<a href="/pmc/articles/PMC5359383/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5359383</span></a>] [<a href="/pubmed/28229249" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28229249</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.ettinger.1997.32534">Ettinger AJ, Feng G, Sanes JR. Epsilon-sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D. <span><span class="ref-journal">J Biol Chem. </span>1997;<span class="ref-vol">272</span>:32534–8.</span> [<a href="/pubmed/9405466" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9405466</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.foncke.2010.288">Foncke EM, Beukers RJ, Tijssen CC, Koelman JH, Tijssen MA. Myoclonus-dystonia and spinocerebellar ataxia type 14 presenting with similar phenotypes: trunk tremor, myoclonus, and dystonia. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2010;<span class="ref-vol">16</span>:288–9.</span> [<a href="/pubmed/19913450" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19913450</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.foncke.2003.1988">Foncke EM, Klein C, Koelman JH, Kramer PL, Schilling K, Muller B, Garrels J, de Carvalho Aguiar P, Liu L, de Froe A, Speelman JD, Ozelius LJ, Tijssen MA. Hereditary myoclonus-dystonia associated with epilepsy. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">60</span>:1988–90.</span> [<a href="/pubmed/12821748" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12821748</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.frucht.2005.1330">Frucht SJ, Bordelon Y, Houghton WH, Reardan D. A pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disorders. <span><span class="ref-journal">Mov Disord. </span>2005;<span class="ref-vol">20</span>:1330–7.</span> [<a href="/pubmed/15986420" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15986420</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.gasser.1998.325">Gasser T. Inherited myoclonus-dystonia syndrome. <span><span class="ref-journal">Adv Neurol. </span>1998;<span class="ref-vol">78</span>:325–34.</span> [<a href="/pubmed/9750929" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9750929</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.gasser.1996.363">Gasser T, Bereznai B, Muller B, Pruszak-Seel R, Damrich R, Deuschl G, Oertel WH. Linkage studies in alcohol-responsive myoclonic dystonia. <span><span class="ref-journal">Mov Disord. </span>1996;<span class="ref-vol">11</span>:363–70.</span> [<a href="/pubmed/8813214" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8813214</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.geiger.2017.216">Geiger JT, Schindler AB, Blauwendraat C, Singer HS, Scholz SW. TUBB2B mutation in an adult patient with myoclonus-dystonia. <span><span class="ref-journal">Case Rep Neurol. </span>2017;<span class="ref-vol">9</span>:216–21.</span> [<a href="/pmc/articles/PMC5618395/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5618395</span></a>] [<a href="/pubmed/28966590" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28966590</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.gerrits.2009.178">Gerrits MC, Foncke EM, Koelman JH, Tijssen MA. Pediatric writer's cramp in myoclonus-dystonia: maternal imprinting hides positive family history. <span><span class="ref-journal">Eur J Paediatr Neurol. </span>2009;<span class="ref-vol">13</span>:178–80.</span> [<a href="/pubmed/18571946" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18571946</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.goetz.2001.129">Goetz CG, Horn SS. Treatment of tremor and dystonia. <span><span class="ref-journal">Neurol Clin. </span>2001;<span class="ref-vol">19</span>:129–44.</span> [<a href="/pubmed/11471761" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11471761</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.grabowski.2003.138">Grabowski M, Zimprich A, Lorenz-Depiereux B, Kalscheuer V, Asmus F, Gasser T, Meitinger T, Strom TM. The epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprinted. <span><span class="ref-journal">Eur J Hum Genet. </span>2003;<span class="ref-vol">11</span>:138–44.</span> [<a href="/pubmed/12634861" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12634861</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.graziola.2019.4">Graziola F, Stregapede F, Travaglini L, Garone G, Verardo M, Bosco L, Pro S, Bertini E, Curatolo P, Vigevano F, Capuano A. A novel KCTD17 mutation is associated with childhood early-onset hyperkinetic movement disorder. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2019;<span class="ref-vol">61</span>:4–6.</span> [<a href="/pubmed/30579817" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30579817</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.grimes.2002.1183">Grimes DA, Han F, Lang AE, St George-Hyssop P, Racacho L, Bulman DE. A novel locus for inherited myoclonus-dystonia on 18p11. <span><span class="ref-journal">Neurology. </span>2002;<span class="ref-vol">59</span>:1183–6.</span> [<a href="/pubmed/12391345" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12391345</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.groen.2015.415">Groen JL, Ritz K, Jalalzadeh H, van der Salm SM, Jongejan A, Mook OR, Haagmans MA, Zwinderman AH, Motazacker MM, Hennekam RC, Baas F, Tijssen MA. RELN rare variants in myoclonus-dystonia. <span><span class="ref-journal">Mov Disord. </span>2015;<span class="ref-vol">30</span>:415–9.</span> [<a href="/pubmed/25648840" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25648840</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.gr_newald.2008.331">Gr&#x000fc;newald A, Djarmati A, Lohmann-Hedrich K, Farrell K, Zeller JA, Allert N, Papengut F, Petersen B, Fung V, Sue CM, O'Sullivan D, Mahant N, Kupsch A, Chuang RS, Wiegers K, Pawlack H, Hagenah J, Ozelius LJ, Stephani U, Schuit R, Lang AE, Volkmann J, M&#x000fc;nchau A, Klein C. Myoclonus-dystonia: significance of large SGCE deletions. <span><span class="ref-journal">Hum Mutat. </span>2008;<span class="ref-vol">29</span>:331–2.</span> [<a href="/pubmed/18205193" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18205193</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.guettard.2008.1380">Guettard E, Portnoi MF, Lohmann-Hedrich K, Keren B, Rossignol S, Winkler S, El Kamel I, Leu S, Apartis E, Vidailhet M, Klein C, Roze E. Myoclonus-dystonia due to maternal uniparental disomy. <span><span class="ref-journal">Arch Neurol. </span>2008;<span class="ref-vol">65</span>:1380–5.</span> [<a href="/pubmed/18852357" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18852357</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.hainque.2016.1729">Hainque E, Vidailhet M, Cozic N, Charbonnier-Beaupel F, Thobois S, Tranchant C, Brochard V, Glibert G, Drapier S, Mutez E, Doe De Maindreville A, Lebouvier T, Hubsch C, Degos B, Bonnet C, Grabli D, Legrand AP, M&#x000e9;neret A, Azulay JP, Bissery A, Zahr N, Clot F, Mallet A, Dupont S, Apartis E, Corvol JC, Roze E. A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia. <span><span class="ref-journal">Neurology. </span>2016;<span class="ref-vol">86</span>:1729–35.</span> [<a href="/pubmed/27053715" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27053715</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.han.2003.244">Han F, Lang AE, Racacho L, Bulman DE, Grimes DA. Mutations in the epsilon-sarcoglycan gene found to be uncommon in seven myoclonus-dystonia families. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">61</span>:244–6.</span> [<a href="/pubmed/12874409" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12874409</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.han.2007.888">Han F, Racacho L, Lang AE, Bulman DE, Grimes DA. Refinement of the DYT15 locus in myoclonus dystonia. <span><span class="ref-journal">Mov Disord. </span>2007;<span class="ref-vol">22</span>:888–92.</span> [<a href="/pubmed/17274032" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17274032</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.haugarvoll.2014.358">Haugarvoll K, Tzoulis C, Tran GT, Karlsen B, Engelsen BA, Knappskog PM, Bindoff LA. Myoclonus-dystonia and epilepsy in a family with a novel epsilon-sarcoglycan mutation. <span><span class="ref-journal">J Neurol. </span>2014;<span class="ref-vol">261</span>:358–62.</span> [<a href="/pubmed/24297365" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24297365</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.hedrich.2004.1229">Hedrich K, Meyer EM, Schule B, Kock N, de Carvalho Aguiar P, Wiegers K, Koelman JH, Garrels J, Durr R, Liu L, Schwinger E, Ozelius LJ, Landwehrmeyer B, Stoessl AJ, Tijssen MA, Klein C. Myoclonus-dystonia: detection of novel, recurrent, and de novo SGCE mutations. <span><span class="ref-journal">Neurology. </span>2004;<span class="ref-vol">62</span>:1229–31.</span> [<a href="/pubmed/15079037" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15079037</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.hemati.2018.2259">Hemati P, Revah-Politi A, Bassan H, Petrovski S, Bilancia CG, Ramsey K, Griffin NG, Bier L, Cho MT, Rosello M, Lynch SA, Colombo S, Weber A, Haug M, Heinzen EL, Sands TT, Narayanan V, Primiano M, Aggarwal VS, Millan F, Sattler-Holtrop SG, Caro-Llopis A, Pillar N, Baker J, Freedman R, Kroes HY, Sacharow S, Stong N, Lapunzina P, Schneider MC, Mendelsohn NJ, Singleton A, Loik Ramey V, Wou K, Kuzminsky A, Monfort S, Weiss M, Doyle S, Iglesias A, Martinez F, Mckenzie F, Orellana C, van Gassen KLI, Palomares M, Bazak L, Lee A, Bircher A, Basel-Vanagaite L, Hafstr&#x000f6;m M, Houge G. C4RCD Research Group; DDD study, Goldstein DB, Anyane-Yeboa K. Refining the phenotype associated with GNB1 mutations: clinical data on 18 newly identified patients and review of the literature. <span><span class="ref-journal">Am J Med Genet A. </span>2018;<span class="ref-vol">176</span>:2259–75.</span> [<a href="/pubmed/30194818" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30194818</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.hjermind.2003.1536">Hjermind LE, Werdelin LM, Eiberg H, Krag-Olsen B, Dupont E, Sorensen SA. A novel mutation in the epsilon-sarcoglycan gene causing myoclonus-dystonia syndrome. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">60</span>:1536–9.</span> [<a href="/pubmed/12743249" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12743249</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.jones.2019.1079">Jones HF, Morales-Briceno H, Barwick K. Myoclonus-dystonia caused by GNB1 mutation responsive to deep brain stimulation. <span><span class="ref-journal">Mov Disord. </span>2019;<span class="ref-vol">34</span>:1079–80.</span> [<a href="/pubmed/31034681" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 31034681</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.klein.2002.675">Klein C, Liu L, Doheny D, Kock N, Muller B, de Carvalho Aguiar P, Leung J, de Leon D, Bressman SB, Silverman J, Smith C, Danisi F, Morrison C, Walker RH, Velickovic M, Schwinger E, Kramer PL, Breakefield XO, Brin MF, Ozelius LJ. Epsilon-sarcoglycan mutations found in combination with other dystonia gene mutations. <span><span class="ref-journal">Ann Neurol. </span>2002;<span class="ref-vol">52</span>:675–9.</span> [<a href="/pubmed/12402271" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12402271</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.kock.2004.231">Kock N, Kasten M, Schule B, Hedrich K, Wiegers K, Kabakci K, Hagenah J, Pramstaller PP, Nitschke MF, Munchau A, Sperner J, Klein C. Clinical and genetic features of myoclonus-dystonia in 3 cases: a video presentation. <span><span class="ref-journal">Mov Disord. </span>2004;<span class="ref-vol">19</span>:231–4.</span> [<a href="/pubmed/14978685" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14978685</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.kosutzka.2019.87">Kosutzka Z, Tisch S, Bonnet C, Ruiz M, Hainque E, Welter ML, Viallet F, Karachi C, Navarro S, Jahanshahi M, Rivaud-Pechoux S, Grabli D, Roze E, Vidailhet M. Long-term GPi-DBS improves motor features in myoclonus-dystonia and enhances social adjustment. <span><span class="ref-journal">Mov Disord. </span>2019;<span class="ref-vol">34</span>:87–94.</span> [<a href="/pubmed/30302819" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30302819</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.kyllerman.1990.270">Kyllerman M, Forsgren L, Sanner G, Holmgren G, Wahlstrom J, Drugge U. Alcohol-responsive myoclonic dystonia in a large family: dominant inheritance and phenotypic variation. <span><span class="ref-journal">Mov Disord. </span>1990;<span class="ref-vol">5</span>:270–9.</span> [<a href="/pubmed/2259350" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2259350</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.lang.1997.127">Lang AE. Essential myoclonus and myoclonic dystonia. <span><span class="ref-journal">Mov Disord. </span>1997;<span class="ref-vol">12</span>:127.</span> [<a href="/pubmed/8990070" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8990070</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.leuzzi.2002.1241">Leuzzi V, Carducci C, Carducci C, Cardona F, Artiola C, Antonozzi I. Autosomal dominant GTP-CH deficiency presenting as a dopa-responsive myoclonus-dystonia syndrome. <span><span class="ref-journal">Neurology. </span>2002;<span class="ref-vol">59</span>:1241–3.</span> [<a href="/pubmed/12391354" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12391354</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.levy.2018.1238">Levy A, Lang AE. Ataxia-telangiectasia: a review of movement disorders, clinical features, and genotype correlations. <span><span class="ref-journal">Mov Disord. </span>2018;<span class="ref-vol">33</span>:1238–47.</span> [<a href="/pubmed/29436738" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29436738</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.lohmann.2017.1078">Lohmann K, Masuho I, Patil DN, Baumann H, Hebert E, Steinr&#x000fc;cke S, Trujillano D, Skamangas NK, Dobricic V, H&#x000fc;ning I, Gillessen-Kaesbach G, Westenberger A, Savic-Pavicevic D, M&#x000fc;nchau A, Oprea G, Klein C, Rolfs A, Martemyanov KA. Novel GNB1 mutations disrupt assembly and function of G protein heterotrimers and cause global developmental delay in humans. <span><span class="ref-journal">Hum Mol Genet. </span>2017;<span class="ref-vol">26</span>:1078–86.</span> [<a href="/pmc/articles/PMC6075543/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6075543</span></a>] [<a href="/pubmed/28087732" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28087732</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.luciano.2014.1423">Luciano AY, Jinnah HA, Pfeiffer RF, Truong DD, Nance MA, LeDoux MS. Treatment of myoclonus-dystonia syndrome with tetrabenazine. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2014;<span class="ref-vol">20</span>:1423–6.</span> [<a href="/pmc/articles/PMC4254189/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4254189</span></a>] [<a href="/pubmed/25406829" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25406829</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.luciano.2009.425">Luciano MS, Ozelius L, Sims K, Raymond D, Liu L, Saunders-Pullman R. Responsiveness to levodopa in epsilon-sarcoglycan deletions. <span><span class="ref-journal">Mov Disord. </span>2009;<span class="ref-vol">24</span>:425–8.</span> [<a href="/pubmed/19133653" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19133653</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.marc_grau.2019.7">Marc&#x000e9;-Grau A, Correa M, Vanegas MI, Mu&#x000f1;oz-Ruiz T, Ferrer-Aparicio S, Baide H, Macaya A, P&#x000e9;rez-Due&#x000f1;as B. Childhood onset progressive myoclonic dystonia due to a de novo KCTD17 splicing mutation. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2019;<span class="ref-vol">61</span>:7–9.</span> [<a href="/pubmed/30642807" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30642807</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.mar_chal.2003.114">Mar&#x000e9;chal L, Raux G, Dumanchin C, Lefebvre G, Deslandre E, Girard C, Campion D, Parain D, Frebourg T, Hannequin D. Severe myoclonus-dystonia syndrome associated with a novel epsilon-sarcoglycan gene truncating mutation. <span><span class="ref-journal">Am J Med Genet. </span>2003;<span class="ref-vol">119B</span>:114–7.</span> [<a href="/pubmed/12707948" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12707948</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.mcnally.1998.27">McNally EM, Ly CT, Kunkel LM. Human epsilon-sarcoglycan is highly related to alpha-sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene. <span><span class="ref-journal">FEBS Lett. </span>1998;<span class="ref-vol">422</span>:27–32.</span> [<a href="/pubmed/9475163" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9475163</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.mencacci.2015.938">Mencacci NE, Rubio-Agusti I, Zdebik A, Asmus F, Ludtmann MH, Ryten M, Plagnol V, Hauser AK, Bandres-Ciga S, Bettencourt C, Forabosco P, Hughes D, Soutar MM, Peall K, Morris HR, Trabzuni D, Tekman M, Stanescu HC, Kleta R, Carecchio M, Zorzi G, Nardocci N, Garavaglia B, Lohmann E, Weissbach A, Klein C, Hardy J, Pittman AM, Foltynie T, Abramov AY, Gasser T, Bhatia KP, Wood NW. A missense mutation in KCTD17 causes autosomal dominant myoclonus-dystonia. <span><span class="ref-journal">Am J Hum Genet. </span>2015;<span class="ref-vol">96</span>:938–47.</span> [<a href="/pmc/articles/PMC4457957/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4457957</span></a>] [<a href="/pubmed/25983243" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25983243</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.m_ller.2002.1303">M&#x000fc;ller B, Hedrich K, Kock N, Dragasevic N, Svetel M, Garrels J, Landt O, Nitschke M, Pramstaller PP, Reik W, Schwinger E, Sperner J, Ozelius L, Kostic V, Klein C. Evidence that paternal expression of the epsilon-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">71</span>:1303–11.</span> [<a href="/pmc/articles/PMC378568/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC378568</span></a>] [<a href="/pubmed/12444570" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12444570</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.nygaard.1999.794">Nygaard TG, Raymond D, Chen C, Nishino I, Greene PE, Jennings D, Heiman GA, Klein C, Saunders-Pullman RJ, Kramer P, Ozelius LJ, Bressman SB. Localization of a gene for myoclonus-dystonia to chromosome 7q21-q31. <span><span class="ref-journal">Ann Neurol. </span>1999;<span class="ref-vol">46</span>:794–8.</span> [<a href="/pubmed/10554001" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10554001</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.oriordan.2004.1456">O'Riordan S, Ozelius LJ, de Carvalho Aguiar P, Hutchinson M, King M, Lynch T. Inherited myoclonus-dystonia and epilepsy: further evidence of an association? <span><span class="ref-journal">Mov Disord. </span>2004;<span class="ref-vol">19</span>:1456–9.</span> [<a href="/pubmed/15389977" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15389977</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.park.2009.2172">Park IS, Kim JS, An JY, Kim YI, Lee KS. Excellent response to oral zolpidem in a sporadic case of the myoclonus dystonia syndrome. <span><span class="ref-journal">Mov Disord. </span>2009;<span class="ref-vol">24</span>:2172–3.</span> [<a href="/pubmed/19735067" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19735067</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.peall.2015.4">Peall KJ, Dijk JM, Saunders-Pullman R, Dreissen YE, van Loon I, Cath D, Kurian MA, Owen MJ, Foncke EM, Morris HR, Gasser T, Bressman S, Asmus F, Tijssen MA. Psychiatric disorders, myoclonus dystonia and SGCE: an international study. <span><span class="ref-journal">Ann Clin Transl Neurol. </span>2015;<span class="ref-vol">3</span>:4–11.</span> [<a href="/pmc/articles/PMC4704478/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4704478</span></a>] [<a href="/pubmed/26783545" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26783545</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.peall.2014.2296">Peall KJ, Kurian MA, Wardle M, Waite AJ, Hedderly T, Lin JP, Smith M, Whone A, Pall H, White C, Lux A, Jardine PE, Lynch B, Kirov G, O'Riordan S, Samuel M, Lynch T, King MD, Chinnery PF, Warner TT, Blake DJ, Owen MJ, Morris HR. SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype. <span><span class="ref-journal">J Neurol. </span>2014;<span class="ref-vol">261</span>:2296–304.</span> [<a href="/pmc/articles/PMC4495322/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4495322</span></a>] [<a href="/pubmed/25209853" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25209853</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.petrovski.2016.1001">Petrovski S, K&#x000fc;ry S, Myers CT, Anyane-Yeboa K, Cogn&#x000e9; B, Bialer M, Xia F, Hemati P, Riviello J, Mehaffey M, Besnard T, Becraft E, Wadley A, Politi AR, Colombo S, Zhu X, Ren Z, Andrews I, Dudding-Byth T, Schneider AL, Wallace G, Rosen ABI, Schelley S, Enns GM, Corre P, Dalton J, Mercier S, Latypova X, Schmitt S, Guzman E, Moore C, Bier L, Heinzen EL, Karachunski P, Shur N, Grebe T, Basinger A, Nguyen JM, B&#x000e9;zieau S, Wierenga K, Bernstein JA, Scheffer IE, Rosenfeld JA, Mefford HC, Isidor B, Goldstein DB, et al.  Germline de novo mutations in GNB1 cause severe neurodevelopmental disability, hypotonia, and seizures. <span><span class="ref-journal">Am J Hum Genet. </span>2016;<span class="ref-vol">98</span>:1001–10.</span> [<a href="/pmc/articles/PMC4863562/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4863562</span></a>] [<a href="/pubmed/27108799" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27108799</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.priori.2000.1706">Priori A, Bertolasi L, Pesenti A, Cappellari A, Barbieri S. Gamma-hydroxybutyric acid for alcohol-sensitive myoclonus with dystonia. <span><span class="ref-journal">Neurology. </span>2000;<span class="ref-vol">54</span>:1706.</span> [<a href="/pubmed/10762526" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10762526</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.popa.2014.612">Popa T, Milani P, Richard A, Hubsch C, Brochard V, Tranchant C, Sadnicka A, Rothwell J, Vidailhet M, Meunier S, Roze E. The neurophysiological features of myoclonus-dystonia and differentiation from other dystonias. <span><span class="ref-journal">JAMA Neurol. </span>2014;<span class="ref-vol">71</span>:612–9.</span> [<a href="/pubmed/24638021" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24638021</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.quinn.1996.119">Quinn NP. Essential myoclonus and myoclonic dystonia. <span><span class="ref-journal">Mov Disord. </span>1996;<span class="ref-vol">11</span>:119–24.</span> [<a href="/pubmed/8684380" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8684380</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.quinn.1988.391">Quinn NP, Rothwell JC, Thompson PD, Marsden CD. Hereditary myoclonic dystonia, hereditary torsion dystonia and hereditary essential myoclonus: an area of confusion. <span><span class="ref-journal">Adv Neurol. </span>1988;<span class="ref-vol">50</span>:391–401.</span> [<a href="/pubmed/3400498" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3400498</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR, Hurles ME, et al.  Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.raymond.2008.588">Raymond D, Saunders-Pullman R, de Carvalho Aguiar P, Schule B, Kock N, Friedman J, Harris J, Ford B, Frucht S, Heiman GA, Jennings D, Doheny D, Brin MF, de Leon Brin D, Multhaupt-Buell T, Lang AE, Kurlan R, Klein C, Ozelius L, Bressman S. Phenotypic spectrum and sex effects in eleven myoclonus-dystonia families with epsilon-sarcoglycan mutations. <span><span class="ref-journal">Mov Disord. </span>2008;<span class="ref-vol">23</span>:588–92.</span> [<a href="/pubmed/18175340" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18175340</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.ritz.2009.653">Ritz K, Gerrits MC, Foncke EM, van Ruissen F, van der Linden C, Vergouwen MD, Bloem BR, Vandenberghe W, Crols R, Speelman JD, Baas F, Tijssen MA. Myoclonus-dystonia: clinical and genetic evaluation of a large cohort. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2009;<span class="ref-vol">80</span>:653–8.</span> [<a href="/pubmed/19066193" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19066193</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.ritz.2011.438">Ritz K, van Schaik BD, Jakobs ME, van Kampen AH, Aronica E, Tijssen MA, Baas F. SGCE isoform characterization and expression in human brain: implications for myoclonus-dystonia pathogenesis? <span><span class="ref-journal">Eur J Hum Genet. </span>2011;<span class="ref-vol">19</span>:438–44.</span> [<a href="/pmc/articles/PMC3060322/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3060322</span></a>] [<a href="/pubmed/21157498" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21157498</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.roze.2008.1010">Roze E, Apartis E, Clot F, Dorison N, Thobois S, Guyant-Marechal L, Tranchant C, Damier P, Doummar D, Bahi-Buisson N, Andr&#x000e9;-Obadia N, Maltete D, Echaniz-Laguna A, Pereon Y, Beaugendre Y, Dupont S, De Greslan T, Jedynak CP, Ponsot G, Dussaule JC, Brice A, D&#x000fc;rr A, Vidailhet M. Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. <span><span class="ref-journal">Neurology. </span>2008;<span class="ref-vol">70</span>:1010–6.</span> [<a href="/pubmed/18362280" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18362280</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.roze.2018.484">Roze E, Lang AE, Vidailhet M. Myoclonus-dystonia: classification, phenomenology, pathogenesis, and treatment. <span><span class="ref-journal">Curr Opin Neurol. </span>2018;<span class="ref-vol">31</span>:484–90.</span> [<a href="/pubmed/29952836" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29952836</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.roze.2015.871">Roze E, Vidailhet M, Hubsch C, Navarro S, Grabli D. Pallidal stimulation for myoclonus-dystonia: Ten years' outcome in two patients. <span><span class="ref-journal">Mov Disord. </span>2015;<span class="ref-vol">30</span>:871–2.</span> [<a href="/pubmed/25787304" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25787304</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.sanjari_moghaddam.2018.116">Sanjari Moghaddam H, Tafakhori A, Darvish H, Mahmoudi-Gharaei J, Jamali F, Aghamollaii V. Treatment of myoclonus-dystonia with carbamazepine. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2018;<span class="ref-vol">53</span>:116–7.</span> [<a href="/pubmed/29853296" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29853296</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.saunderspullman.2012.649">Saunders-Pullman R, Raymond D, Stoessl AJ, Hobson D, Nakamura K, Pullman S, Lefton D, Okun MS, Uitti R, Sachdev R, Stanley K, San Luciano M, Hagenah J, Gatti R, Ozelius LJ, Bressman SB. Variant ataxia-telangiectasia presenting as primary-appearing dystonia in Canadian Mennonites. <span><span class="ref-journal">Neurology. </span>2012;<span class="ref-vol">78</span>:649–57.</span> [<a href="/pmc/articles/PMC3286230/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3286230</span></a>] [<a href="/pubmed/22345219" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22345219</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.scheidtmann.2000.839">Scheidtmann K, Muller F, Hartmann E, Koenig E. Familial myoclonus-dystonia syndrome associated with panic attacks. <span><span class="ref-journal">Nervenarzt. </span>2000;<span class="ref-vol">71</span>:839–42.</span> [<a href="/pubmed/11082816" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11082816</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.sch_le.2004.1181">Sch&#x000fc;le B, Kock N, Svetel M, Dragasevic N, Hedrich K, De Carvalho Aguiar P, Liu L, Kabakci K, Garrels J, Meyer EM, Berisavac I, Schwinger E, Kramer PL, Ozelius LJ, Klein C, Kostic V. Genetic heterogeneity in ten families with myoclonus-dystonia. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2004;<span class="ref-vol">75</span>:1181–5.</span> [<a href="/pmc/articles/PMC1739169/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1739169</span></a>] [<a href="/pubmed/15258227" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15258227</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.sheridan.2013.368">Sheridan MB, Bytyci Telegrafi A, Stinnett V, Umeh CC, Mari Z, Dawson TM, Bodurtha J, Batista DA. Myoclonus-dystonia and Silver-Russell syndrome resulting from maternal uniparental disomy of chromosome 7. <span><span class="ref-journal">Clin Genet. </span>2013;<span class="ref-vol">84</span>:368–72.</span> [<a href="/pmc/articles/PMC3657309/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3657309</span></a>] [<a href="/pubmed/23237735" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23237735</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.stark.2010.2342">Stark Z, Ryan MM, Bruno DL, Burgess T, Savarirayan R. Atypical Silver-Russell phenotype resulting from maternal uniparental disomy of chromosome 7. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:2342–5.</span> [<a href="/pubmed/20684011" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20684011</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.steinr_cke.2016.e106">Steinr&#x000fc;cke S, Lohmann K, Domingo A, Rolfs A, B&#x000e4;umer T, Spiegler J, Hartmann C, M&#x000fc;nchau A. Novel GNB1 missense mutation in a patient with generalized dystonia, hypotonia, and intellectual disability. <span><span class="ref-journal">Neurol Genet. </span>2016;<span class="ref-vol">2</span>:e106.</span> [<a href="/pmc/articles/PMC5022844/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5022844</span></a>] [<a href="/pubmed/27668284" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27668284</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.suchowersky.2000.332">Suchowersky O, Davis JL, et al.  Thalamic surgery for essential myoclonus results in clinical but not functional improvement. <span><span class="ref-journal">Mov Disord. </span>2000;<span class="ref-vol">15</span>(S3):332.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.tezenas_du_montcel.2006.394">Tezenas du Montcel S, Clot F, Vidailhet M, Roze E, Damier P, Jedynak CP, Camuzat A, Lagueny A, Vercueil L, Doummar D, Guyant-Mar&#x000e9;chal L, Houeto JL, Ponsot G, Thobois S, Cournelle MA, Durr A, Durif F, Echenne B, Hannequin D, Tranchant C, Brice A, et al.  Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes. <span><span class="ref-journal">J Med Genet. </span>2006;<span class="ref-vol">43</span>:394–400.</span> [<a href="/pmc/articles/PMC2564513/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2564513</span></a>] [<a href="/pubmed/16227522" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16227522</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.trottenberg.2001.769">Trottenberg T, Meissner W, Kabus C, Arnold G, Funk T, Einhaupl KM, Kupsch A. Neurostimulation of the ventral intermediate thalamic nucleus in inherited myoclonus-dystonia syndrome. <span><span class="ref-journal">Mov Disord. </span>2001;<span class="ref-vol">16</span>:769–71.</span> [<a href="/pubmed/11481711" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11481711</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.valente.2005.737">Valente EM, Edwards MJ, Mir P, DiGiorgio A, Salvi S, Davis M, Russo N, Bozi M, Kim HT, Pennisi G, Quinn N, Dallapiccola B, Bhatia KP. The epsilon-sarcoglycan gene in myoclonic syndromes. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">64</span>:737–9.</span> [<a href="/pubmed/15728306" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15728306</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.vidailhet.2001.1213">Vidailhet M, Tassin J, Durif F, Nivelon-Chevallier A, Agid Y, Brice A, Durr A. A major locus for several phenotypes of myoclonus&#x02014;dystonia on chromosome 7q. <span><span class="ref-journal">Neurology. </span>2001;<span class="ref-vol">56</span>:1213–6.</span> [<a href="/pubmed/11342690" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11342690</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.xiao.2017.52">Xiao J, Vemula SR, Xue Y, Khan MM, Carlisle FA, Waite AJ, Blake DJ, Dragatsis I, Zhao Y, LeDoux MS. Role of major and brain-specific Sgce isoforms in the pathogenesis of myoclonus-dystonia syndrome. <span><span class="ref-journal">Neurobiol Dis. </span>2017;<span class="ref-vol">98</span>:52–65.</span> [<a href="/pmc/articles/PMC5283163/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5283163</span></a>] [<a href="/pubmed/27890709" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27890709</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.zhang.2019.e933">Zhang YQ, Wang JW, Wang YP, Zhang XH, Li JP. Thalamus stimulation for myoclonus dystonia syndrome: five cases and long-term follow-up. <span><span class="ref-journal">World Neurosurg. </span>2019;<span class="ref-vol">122</span>:e933–9.</span> [<a href="/pubmed/30419400" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30419400</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myo-dystonia.REF.zimprich.2001.66">Zimprich A, Grabowski M, Asmus F, Naumann M, Berg D, Bertram M, Scheidtmann K, Kern P, Winkelmann J, Muller-Myhsok B, Riedel L, Bauer M, Muller T, Castro M, Meitinger T, Strom TM, Gasser T. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">29</span>:66–9.</span> [<a href="/pubmed/11528394" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11528394</span></a>]</div></li></ul></div></div><div id="myo-dystonia.Chapter_Notes"><h2 id="_myo-dystonia_Chapter_Notes_">Chapter Notes</h2><div id="myo-dystonia.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>8 August 2019 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>26 January 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>19 December 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>11 June 2004 (ljo/cd) Revision: testing</div></li><li class="half_rhythm"><div>21 May 2003 (me) Review posted live</div></li><li class="half_rhythm"><div>5 May 2003 (ljo) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1414</span><span class="label">PMID: <a href="/pubmed/20301587" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301587</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/etha/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/short/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1414&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1414/?report=reader">PubReader</a></li><li><a href="/books/NBK1414/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1414" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1414" style="display:none" title="Cite this Page"><div class="bk_tt">Raymond D, Saunders-Pullman R, Ozelius L. SGCE Myoclonus-Dystonia. 2003 May 21 [Updated 2019 Aug 8]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1414/pdf/Bookshelf_NBK1414.pdf">PDF version of this page</a> (511K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#myo-dystonia.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#myo-dystonia.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#myo-dystonia.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#myo-dystonia.Genetically_Related_Allelic" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#myo-dystonia.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#myo-dystonia.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#myo-dystonia.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#myo-dystonia.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#myo-dystonia.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#myo-dystonia.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#myo-dystonia.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=8910[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SGCE</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1484270" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1484270" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1484270" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1484270" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29697234" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KMT2B</i>-Related Dystonia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KMT2B</i>-Related Dystonia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Abela L, Kurian MA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30605297" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> DYT-GNAL</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> DYT-GNAL<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Deutschländer AB, Wszolek ZK. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22040906" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Abnormal nuclear envelope in the cerebellar Purkinje cells and impaired motor learning in DYT11 myoclonus-dystonia mouse models.</a><span class="source">[Behav Brain Res. 2012]</span><div class="brieflinkpop offscreen_noflow">Abnormal nuclear envelope in the cerebellar Purkinje cells and impaired motor learning in DYT11 myoclonus-dystonia mouse models.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Yokoi F, Dang MT, Yang G, Li J, Doroodchi A, Zhou T, Li Y. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Behav Brain Res. 2012 Feb 1; 227(1):12-20. Epub 2011 Oct 21.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22080833" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Abnormal nuclear envelopes in the striatum and motor deficits in DYT11 myoclonus-dystonia mouse models.</a><span class="source">[Hum Mol Genet. 2012]</span><div class="brieflinkpop offscreen_noflow">Abnormal nuclear envelopes in the striatum and motor deficits in DYT11 myoclonus-dystonia mouse models.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Yokoi F, Dang MT, Zhou T, Li Y. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Hum Mol Genet. 2012 Feb 15; 21(4):916-25. Epub 2011 Nov 11.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31413899" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Gait Impairment in Myoclonus-Dystonia (DYT-&lt;i&gt;SGCE&lt;/i&gt;).</a><span class="source">[Tremor Other Hyperkinet Mov (N...]</span><div class="brieflinkpop offscreen_noflow">Gait Impairment in Myoclonus-Dystonia (DYT-&lt;i&gt;SGCE&lt;/i&gt;).<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Haeri G, Shahidi G, Fasano A, Rohani M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Tremor Other Hyperkinet Mov (N Y). 2019; 9. Epub 2019 Aug 2.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301587" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301587" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040d4239a66ee2ba57c6dc">SGCE Myoclonus-Dystonia - GeneReviews®</a><div class="ralinkpop offscreen_noflow">SGCE Myoclonus-Dystonia - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:30:42-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D0A34E040AF810000000000E80058&amp;ncbi_session=CE8D0A34E040D421_0232SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1414%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1414&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1414/&amp;ncbi_pagename=SGCE Myoclonus-Dystonia - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D0A34E040D421_0232SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>